Improving Immune Checkpoint Blockade Efficacy in Melanoma Brain Metastases through Myddosomal inhibition with Emavusertib.

Saved in:
Bibliographic Details
Title: Improving Immune Checkpoint Blockade Efficacy in Melanoma Brain Metastases through Myddosomal inhibition with Emavusertib.
Authors: Von Roemeling CA; University of Florida Gainesville, FL United States., Doonan BP; Mayo Clinic United States., Carpenter SL; University of Florida Gainesville, FL United States., Patel JA; University of Florida Gainesville, FL United States., Jobin GW; University of Florida Gainesville, FL United States., Yang C; Preston A. Wells, Jr. Center for Brain Tumor Therapy, UF Brain Tumor Immunotherapy Program, University of Florida Gainesville, FL United States., Bhatia A; University of Florida Gainesville, FL United States., Trivedi V; University of Florida Gainesville, FL United States., Acevedo A; University of Florida United States., Elliott T; University of Florida Gainesville, FL United States., Archibald V; University of Florida United States., Speakman SM; University of Florida Gainesville, FL United States., Matich E; National Cancer Institute Frederick, Maryland United States., Mitchell DA; University of Florida Gainesville, FL United States.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2026 Jun 24. Date of Electronic Publication: 2026 Jun 24.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42338303
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Improving Immune Checkpoint Blockade Efficacy in Melanoma Brain Metastases through Myddosomal inhibition with Emavusertib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Von+Roemeling+CA%22">Von Roemeling CA</searchLink>; University of Florida Gainesville, FL United States.<br /><searchLink fieldCode="AU" term="%22Doonan+BP%22">Doonan BP</searchLink>; Mayo Clinic United States.<br /><searchLink fieldCode="AU" term="%22Carpenter+SL%22">Carpenter SL</searchLink>; University of Florida Gainesville, FL United States.<br /><searchLink fieldCode="AU" term="%22Patel+JA%22">Patel JA</searchLink>; University of Florida Gainesville, FL United States.<br /><searchLink fieldCode="AU" term="%22Jobin+GW%22">Jobin GW</searchLink>; University of Florida Gainesville, FL United States.<br /><searchLink fieldCode="AU" term="%22Yang+C%22">Yang C</searchLink>; Preston A. Wells, Jr. Center for Brain Tumor Therapy, UF Brain Tumor Immunotherapy Program, University of Florida Gainesville, FL United States.<br /><searchLink fieldCode="AU" term="%22Bhatia+A%22">Bhatia A</searchLink>; University of Florida Gainesville, FL United States.<br /><searchLink fieldCode="AU" term="%22Trivedi+V%22">Trivedi V</searchLink>; University of Florida Gainesville, FL United States.<br /><searchLink fieldCode="AU" term="%22Acevedo+A%22">Acevedo A</searchLink>; University of Florida United States.<br /><searchLink fieldCode="AU" term="%22Elliott+T%22">Elliott T</searchLink>; University of Florida Gainesville, FL United States.<br /><searchLink fieldCode="AU" term="%22Archibald+V%22">Archibald V</searchLink>; University of Florida United States.<br /><searchLink fieldCode="AU" term="%22Speakman+SM%22">Speakman SM</searchLink>; University of Florida Gainesville, FL United States.<br /><searchLink fieldCode="AU" term="%22Matich+E%22">Matich E</searchLink>; National Cancer Institute Frederick, Maryland United States.<br /><searchLink fieldCode="AU" term="%22Mitchell+DA%22">Mitchell DA</searchLink>; University of Florida Gainesville, FL United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2026 Jun 24. <i>Date of Electronic Publication: </i>2026 Jun 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42338303
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-25-0349
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Improving Immune Checkpoint Blockade Efficacy in Melanoma Brain Metastases through Myddosomal inhibition with Emavusertib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Von Roemeling CA
      – PersonEntity:
          Name:
            NameFull: Doonan BP
      – PersonEntity:
          Name:
            NameFull: Carpenter SL
      – PersonEntity:
          Name:
            NameFull: Patel JA
      – PersonEntity:
          Name:
            NameFull: Jobin GW
      – PersonEntity:
          Name:
            NameFull: Yang C
      – PersonEntity:
          Name:
            NameFull: Bhatia A
      – PersonEntity:
          Name:
            NameFull: Trivedi V
      – PersonEntity:
          Name:
            NameFull: Acevedo A
      – PersonEntity:
          Name:
            NameFull: Elliott T
      – PersonEntity:
          Name:
            NameFull: Archibald V
      – PersonEntity:
          Name:
            NameFull: Speakman SM
      – PersonEntity:
          Name:
            NameFull: Matich E
      – PersonEntity:
          Name:
            NameFull: Mitchell DA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 06
              Text: 2026 Jun 24
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1